GCTK · NASDAQ
Glucotrack (GCTK) Stock Price & Fundamentals
Glucotrack (GCTK) closed at $566.38 on Oct 9, 2026, up 0.33% from the previous close of $564.52.
Share price, past year
1Y +12.55%Monthly closing prices
| Date | Close |
|---|---|
| Oct 9, 2026 | $566.38 |
| Sep 30, 2026 | $562.18 |
| Aug 31, 2026 | $561.84 |
| Jul 31, 2026 | $528.23 |
| Jun 30, 2026 | $492.52 |
| May 29, 2026 | $481.32 |
| Apr 30, 2026 | $473.50 |
| Mar 31, 2026 | $466.70 |
| Feb 27, 2026 | $476.06 |
| Jan 30, 2026 | $503.74 |
| Dec 31, 2025 | $496.21 |
| Nov 28, 2025 | $498.11 |
| Oct 31, 2025 | $503.59 |
Key statistics
- Market cap
- $3.55B
- P/E (TTM)
- —
- EPS (TTM)
- −$15.13
- Revenue (TTM)
- —
- Net income (TTM)
- −$15.95M
- Shares outstanding
- 6.3M
- Dividend yield
- —
- 52-week range
- $458.19 – $575.42
Glucotrack's market cap is $3.55B, based on a share price of $566.38 and 6.3M shares outstanding as of Jun 30, 2026.
Financials
Glucotrack reported revenue of $208.00K for fiscal 2019, down 100.00% from fiscal 2018.
Glucotrack reported a net loss of $19.39M in fiscal 2025.
Annual revenue
| Fiscal year | Revenue | Growth | Net income | Net margin | EPS (diluted) | Free cash flow |
|---|---|---|---|---|---|---|
| FY2019ended Dec 31, 2019 | $208.00K | −100.0% | $3.52M | 1,690.4% | −$0.02 | −$3.92M |
| FY2018ended Dec 31, 2018 | $17.00B | +2,883,885.7% | −$6.72M | −0.0% | −$4.74 | −$4.90M |
| FY2017ended Dec 31, 2017 | $589.46K | −3.6% | $10.33M | 1,752.2% | −$1.87 | −$5.91M |
| FY2016ended Dec 31, 2016 | $611.69K | +327.3% | −$5.41M | −884.4% | −$1.08 | −$5.39M |
| FY2015ended Dec 31, 2015 | $143.17K | +139.5% | — | — | — | −$4.71M |
| FY2014ended Dec 31, 2014 | $59.78K | — | — | — | — | — |
| Quarter | Revenue | Net income | EPS (diluted) |
|---|---|---|---|
| Q2 FY2020ended Jun 30, 2020 | $97.00 | — | — |
| Q1 FY2020ended Mar 31, 2020 | $2.17K | — | — |
| Q4 FY2019ended Dec 31, 2019 | $67.75K | — | — |
| Q3 FY2019ended Sep 30, 2019 | $4.18K | — | — |
| Q2 FY2019ended Jun 30, 2019 | $110.52K | — | — |
| Q1 FY2019ended Mar 31, 2019 | $25.56K | — | — |
| Q2 FY2018ended Jun 30, 2018 | $15.28K | — | — |
| Q1 FY2018ended Mar 31, 2018 | $28.21K | — | — |
Company profile
- Name
- Glucotrack, Inc.
- Ticker
- GCTK
- Exchange
- NASDAQ
- Industry (SEC SIC)
- Surgical & Medical Instruments & Apparatus
- Headquarters
- 301 Rt 17 North, Suite 800, Rutherford, NJ 07070
- Incorporated in
- DE
- Fiscal year ends
- December
- SEC CIK
- 0001506983
Recent SEC filings
- Sep 28, 2026
- Sep 24, 2026
- Sep 23, 2026
- Sep 18, 2026
- Sep 14, 2026
- Sep 11, 2026
- Sep 9, 2026
- Aug 28, 2026
Frequently asked questions
What is Glucotrack's stock price?
Glucotrack (GCTK) closed at $566.38 on Oct 9, 2026, up 0.33% from the previous close of $564.52.
What is Glucotrack's market cap?
Glucotrack's market cap is $3.55B, based on a share price of $566.38 and 6.3M shares outstanding as of Jun 30, 2026.
How much revenue does Glucotrack make?
Glucotrack reported revenue of $208.00K for fiscal 2019, down 100.00% from fiscal 2018.
Does Glucotrack pay a dividend?
Glucotrack's recent filings report no dividends declared over the last four quarters.
Sources and methodology
Fundamentals come from Glucotrack, Inc.'s filings with the SEC (EDGAR XBRL company facts). Fourth-quarter figures that companies don't report separately are calculated as the fiscal year minus the first three quarters. Trailing twelve-month (TTM) figures sum the latest four quarters. Prices are generated sample data for development. Last updated Oct 9, 2026. Data sources and disclosures